Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Behavioral and psychiatric symptoms in prion disease.

Thompson A, MacKay A, Rudge P, Lukic A, Porter MC, Lowe J, Collinge J, Mead S.

Am J Psychiatry. 2014 Mar;171(3):265-74. doi: 10.1176/appi.ajp.2013.12111460. Review.

PMID:
24585329
2.

[Psychiatric manifestations by prions. A narrative review].

Carrillo Robles D, García Maldonado G.

Rev Colomb Psiquiatr. 2016 Apr-Jun;45(2):124-32. doi: 10.1016/j.rcp.2015.07.005. Epub 2015 Sep 15. Review. Spanish.

PMID:
27132762
3.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

4.

Genome-wide association study of behavioural and psychiatric features in human prion disease.

Thompson AG, Uphill J, Lowe J, Porter MC, Lukic A, Carswell C, Rudge P, MacKay A, Collinge J, Mead S.

Transl Psychiatry. 2015 Apr 21;5:e552. doi: 10.1038/tp.2015.42.

5.

The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study.

Selbaek G, Kirkevold Ø, Engedal K.

Am J Geriatr Psychiatry. 2008 Jul;16(7):528-36. doi: 10.1097/JGP.0b013e318167ae76.

PMID:
18591573
6.

Treatment of acute agitation in psychotic disorders.

Mohr P, Pecenák J, Svestka J, Swingler D, Treuer T.

Neuro Endocrinol Lett. 2005 Aug;26(4):327-35. Review.

PMID:
16136016
7.

[Alpha-interferon and mental disorders].

Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D.

Encephale. 2001 Jul-Aug;27(4):308-17. Review. French.

PMID:
11686052
8.

[Psychiatric disorders in adult form of Niemann-Pick disease type C].

Maubert A, Hanon C, Sedel F.

Encephale. 2016 Jun;42(3):208-13. doi: 10.1016/j.encep.2015.11.003. Epub 2015 Dec 23. French.

PMID:
26727648
9.

Antidepressants for agitation and psychosis in dementia.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Review.

PMID:
21328305
10.

Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions.

Kuppuswamy PS, Takala CR, Sola CL.

Gen Hosp Psychiatry. 2014 Jul-Aug;36(4):388-91. doi: 10.1016/j.genhosppsych.2014.02.010. Epub 2014 Mar 5. Review.

PMID:
24731834
11.

Behavioral complications and their treatment in Alzheimer's disease.

Devanand DP.

Geriatrics. 1997 Sep;52 Suppl 2:S37-9.

PMID:
9307585
12.

Psychotropic medication use in people with developmental disabilities.

Curtis JL.

Md Med J. 1997 Oct;46(9):481-5. Review.

PMID:
9327650
13.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C.

Mov Disord. 2011 Oct;26 Suppl 3:S42-80. doi: 10.1002/mds.23884. Review.

14.

Psychotropic effects of antiepileptic drugs.

Ettinger AB.

Neurology. 2006 Dec 12;67(11):1916-25. Review.

PMID:
17159095
15.

[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

Bret P, Bret MC, Queuille E.

Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. French.

PMID:
19393381
16.

Major uses of psychopharmacology in the emergency department.

Glod CA.

J Emerg Nurs. 1994 Feb;20(1):33-7; quiz 37-9. No abstract available.

PMID:
8126944
17.

[Affective and psychotic disorders in multiple sclerosis].

Pozuelo-Moyano B, Benito-León J.

Rev Neurol. 2015 Dec 1;61(11):503-8. Review. Spanish.

18.

Audit of antipsychotic prescribing in a private psychiatric hospital.

Botvinik L, Ng C, Schweitzer I.

Australas Psychiatry. 2004 Sep;12(3):227-33.

PMID:
15715780
19.

Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.

Sultzer DL, Davis SM, Tariot PN, Dagerman KS, Lebowitz BD, Lyketsos CG, Rosenheck RA, Hsiao JK, Lieberman JA, Schneider LS; CATIE-AD Study Group.

Am J Psychiatry. 2008 Jul;165(7):844-54. doi: 10.1176/appi.ajp.2008.07111779. Epub 2008 Jun 2.

20.

Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales.

Tariot PN, Loy R, Ryan JM, Porsteinsson A, Ismail S.

Adv Drug Deliv Rev. 2002 Dec 7;54(12):1567-77. Review.

PMID:
12453674

Supplemental Content

Support Center